By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Taysha Gene Therapies, Inc. (TSHA) Q1 2025 Earnings Call Transcript
News

Taysha Gene Therapies, Inc. (TSHA) Q1 2025 Earnings Call Transcript

News
Last updated: 2025/05/15 at 6:26 PM
By News
Share
2 Min Read
SHARE

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET

Company Participants

Hayleigh Collins – Senior Director, Corporate Communications and Investor Relations
Sean P. Nolan – Chief Executive Officer
Sukumar Nagendran – President and Head of R&D
Kamran Alam – Chief Financial Officer

Conference Call Participants

Kristen Kluska – Cantor Fitzgerald
Gil Blum – Needham and Company
Maury Raycroft – Jefferies
Yanan Zhu – Wells Fargo
Biren Amin – Piper Sandler
Whitney Ijem – Canaccord Genuity
Jack Allen – Baird
Joon Lee – Truist Securities
Silvan Tuerkcan – Citizens
Malcolm Hoffman – BMO Capital Markets

Operator

Greetings, and welcome to the Taysha Gene Therapies First Quarter 2025 Earnings Call.

At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Hayleigh Collins, Director, Head of Corporate Communications. Please go ahead.

Hayleigh Collins

Thank you. Good morning, and welcome to Taysha’s first quarter 2025 financial results and corporate update conference call.

Earlier today, Taysha issued a press release announcing financial results for the first quarter ended March 31, 2025. A copy of this press release is available on the company’s website and through our SEC filings.

Joining me on today’s call are Sean Nolan, Taysha’s Chief Executive Officer; Sukumar Nagendran, President and Head of R&D; and Kamran Alam, Chief Financial Officer. We will hold a question-and-answer session following our prepared remarks.

Please note that on today’s call, we will be making forward-looking statements, including statements concerning the potential of TSHA-102, including the reproducibility and durability of any favorable results initially seen in the patient’s dose to-date in clinical trials to positively impact quality of life and alter the course

Read the full article here

News May 15, 2025 May 15, 2025
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

DBMF: A Managed Futures Strategy That Can Mitigate Correlation Risk In A Portfolio

By News
News

CEF Insights: CAPIX Is An Interval Fund For Broader Private Credit Access

By News
News

Undercovered Dozen: Roku, Merck, Chevron And More

By News
News

Microsoft: Record High Price Is A New Beginning (Technical Analysis) (NASDAQ:MSFT)

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?